Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis

BACKGROUND: Ezetimibe-statin combination therapy has been found to reduce low density lipoprotein cholesterol levels and the risk of major adverse cardiovascular events (MACEs) in large trials. We sought to examine the differential effect of ezetimibe on MACEs when added to statins according to the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Endocrinol Metab (Seoul)
Autori principali: Hong, Namki, Lee, Yong-ho, Tsujita, Kenichi, Gonzalez, Jorge A., Kramer, Christopher M., Kovarnik, Tomas, Kouvelos, George N., Suzuki, Hiromichi, Han, Kyungdo, Lee, Chan Joo, Park, Sung Ha, Lee, Byung-Wan, Cha, Bong-Soo, Kang, Eun Seok
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Endocrine Society 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6021322/
https://ncbi.nlm.nih.gov/pubmed/29766679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2018.33.2.219
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi